Neuralstem Announces Publication of a Study in Nature Medicine Showing Benefits of NSI-566 in a Primate Model of Spinal Cord Injury

– NSI-566 shown to have restorative function in primate paralysis model –

– NSI-566 transplantation resulted in measurable improvement in forelimb function –

GERMANTOWN, Md., March 13, 2018 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system

Read More